Personalized medicine: paradigm shift in ALK positive non-small cell lung cancer: a case report

BACKGROUND: Since the identification of multiple therapeutic targets, as is the case of anaplastic lymphoma kinase (ALK) translocation, the paradigm of treating patients with non-small cell lung cancer (NSCLC) has improved. In order to guarantee the possibility of longer survival outcomes with a bet...

Descripción completa

Detalles Bibliográficos
Autores principales: Barreira, João Vasco, Mendes, José Leão, Parmanande, Anuraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474633/
https://www.ncbi.nlm.nih.gov/pubmed/37658466
http://dx.doi.org/10.1186/s13256-023-04107-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474633/
https://www.ncbi.nlm.nih.gov/pubmed/37658466
http://dx.doi.org/10.1186/s13256-023-04107-5

Ejemplares similares